Hans Glemstedt
Plus aucun poste en cours
Profil
Hans Glemstedt formerly worked at Biovitrum AB, as Director, Silex Microsystems AB, as Director, Swedish Orphan Biovitrum AB, as Director from 2009 to 2011, and Startupfactory AB, as Managing Partner.
Mr. Glemstedt received his graduate degree from Stockholm School of Economics.
Anciens postes connus de Hans Glemstedt
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Directeur/Membre du Conseil | 28/04/2011 |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 13/05/2010 |
Startupfactory AB
 Startupfactory AB Investment ManagersFinance Startupfactory is an early stage Nordic venture capital firm based in Stockholm investing in Nordic companies and teams in the IT, datacom and telecom industries. The people at Startupfactory have long experience from building companies in the IT, datacom and telecom industries and know that building companies takes long time and requires unexpected amounts of energy and work. Starupfactory is currently focusing on development of its current portfolio of companies. | Corporate Officer/Principal | 18/01/2007 |
Silex Microsystems AB
 Silex Microsystems AB Electronic Production EquipmentElectronic Technology Silex Microsystems AB is a holding company that manufactures customized Micro Electro Mechanical Systems (MEMS) products. The firm operates as an independent MEMS foundry. Its product MEMS, which are complex mechanical and electrical systems are built in micro scale on one single chip. Its product is divided in categories such as: sensors, actuators, and basic three-dimensional structures. The company was founded by Johan Edvard Soren Kalvesten in October 2000 and is headquartered in Jarfalla, Sweden. | Directeur/Membre du Conseil | - |
Formation de Hans Glemstedt
| Stockholm School of Economics | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Startupfactory AB
Startupfactory AB Investment ManagersFinance Startupfactory is an early stage Nordic venture capital firm based in Stockholm investing in Nordic companies and teams in the IT, datacom and telecom industries. The people at Startupfactory have long experience from building companies in the IT, datacom and telecom industries and know that building companies takes long time and requires unexpected amounts of energy and work. Starupfactory is currently focusing on development of its current portfolio of companies. | Finance |
Silex Microsystems AB
Silex Microsystems AB Electronic Production EquipmentElectronic Technology Silex Microsystems AB is a holding company that manufactures customized Micro Electro Mechanical Systems (MEMS) products. The firm operates as an independent MEMS foundry. Its product MEMS, which are complex mechanical and electrical systems are built in micro scale on one single chip. Its product is divided in categories such as: sensors, actuators, and basic three-dimensional structures. The company was founded by Johan Edvard Soren Kalvesten in October 2000 and is headquartered in Jarfalla, Sweden. | Electronic Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
